StockGlow

NovAccess Global Inc. (XSNX)

Develops immunotherapy drugs that train patients' immune systems to fight brain tumors.

$0.00+0.00%Healthcare
Compare XSNX with
StockGlow Score
21
Leaning Bearish
BearishBullish
1 year ago+0.0%

The outlook

XSNX is trading at its 52-week low with a mixed price trend against moving averages. Analyst coverage appears thin or unavailable for this micro-cap stock. The overall sentiment leans bearish based on current market data.

What’s behind the score

Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$6,165
52-wk high
$0.05
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

SOENSolar Enertech Corp.$0.00+0.00%SPIRSpire Global, Inc.$11.37+1.79%BCONBeacon Holding Company, Inc.$12.25-1.21%RGUSREGI U.S., Inc.$0.00+0.00%XDSLmPhase Technologies, Inc.$0.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy